Banard Charlene A. 4
4 · Atara Biotherapeutics, Inc. · Filed May 18, 2023
Insider Transaction Report
Form 4
Banard Charlene A.
EVP, Chief Technical Officer
Transactions
- Sale
Common Stock
2023-05-16$2.04/sh−19,040$38,784→ 276,010 total
Footnotes (2)
- [F1]Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement.
- [F2]The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on May 16, 2023 and May 17, 2023 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employee.